Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

BIOMARIN PHARMACEUTICAL INC (BMRN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

BIOMARIN PHARMACEUTICAL INC (BMRN), most recent 12 months reported: revenue $3.41B, net income $72.97M, free cash flow $738.18M. Latest balance sheet on file: liquid cash $874M, total debt $4.19B, net cash -$3.31B. From SEC filings. Others in Pharmaceutical Preparations: Elanco Animal Health Incorporated · ALNYLAM PHARMACEUTICALS, INC. · Jazz Pharmaceuticals plc · Perrigo Company plc · United Therapeutics Corporation · AMNEAL PHARMACEUTICALS, INC. · Royalty Pharma plc · SAREPTA THERAPEUTICS, INC.

Stock screener

Watchlist